Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on September 15, 2026

an hour ago

Templafy menghadirkan Document Agents ke Claude, ChatGPT, dan Microsoft Copilot melalui MCP

Indeterminate GlobeNewswire

an hour ago

テンプラファイ、MCPを通じてクロード、チャットGPT、マイクロソフト・コパイロットにドキュメント・エージェントを導入

Indeterminate GlobeNewswire

an hour ago

Templafy membawa Document Agents ke Claude, ChatGPT dan Microsoft Copilot melalui MCP

Indeterminate GlobeNewswire

an hour ago

Templafy Inclui Agentes de Documentos no Claude, ChatGPT e Microsoft Copilot com o MCP

Indeterminate GlobeNewswire

an hour ago

Templafy นำ Document Agents มาใช้งานบน Claude, ChatGPT และ Microsoft Copilot ผ่าน MCP

Indeterminate GlobeNewswire

an hour ago

Templafy 通过 MCP 将文档智能体接入 Claude、ChatGPT 和 Microsoft Copilot

Indeterminate GlobeNewswire

an hour ago

Templafy 透過 MCP 將文件代理帶到 Claude、ChatGPT 及 Microsoft Copilot

Indeterminate GlobeNewswire

an hour ago

Ontario Healthcare Stakeholders Unite on Shared Action Plan to Reduce Tobacco and Nicotine Dependence

Indeterminate GlobeNewswire

an hour ago

PageUp Paige Named a 2026 Top HR Product of the Year by HR Executive

Indeterminate GlobeNewswire

an hour ago

VEON and Beeline Kazakhstan Sign Payments Cooperation Memorandum with National Bank of Kazakhstan

Indeterminate GlobeNewswire

an hour ago

PolarityBio Announces FDA Acceptance for Filing of SkinTE® BLA with Priority Review in Diabetic Foot Ulcers

Indeterminate GlobeNewswire

an hour ago

Axiom Biosciences Expands Manufacturing and Clinical Development Capabilities Through Partnership with GeneFab

Indeterminate GlobeNewswire

an hour ago

Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™

Indeterminate GlobeNewswire

an hour ago

Remedy Plan Therapeutics Announces Multiple Development and Corporate Milestones as First-In-Class Hyperbolic NAMPT Inhibitor, RPT1G, Advances in Phase 1 Dose Escalation Trial in AML/MDS

Indeterminate GlobeNewswire

an hour ago

BlossomHill Therapeutics Presents Updated Data from Ongoing Phase 1/2 SOLARA Trial Demonstrating Encouraging Anti-Tumor Activity of OMNI-EGFR™ Inhibitor BH-30643 in EGFR C797S-Positive NSCLC at IASLC 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

an hour ago

Crewscope Launches AI-Native Field Intelligence Platform, Turning Decades of Lost Frontline Knowledge Into Foresight for Heavy Industry

Indeterminate GlobeNewswire

an hour ago

Aeluma Executes Strategic Agreement with Sumitomo Chemical Advanced Technologies for Wafer Production for AI Datacom

Indeterminate GlobeNewswire

an hour ago

GoldHaven Advances Tungsten Drilling at Magno Project, British Columbia

Indeterminate GlobeNewswire

an hour ago

Ongwe Minerals Commences Maiden Drill Campaign at Its Newly Discovered Nguni Prospect, Namibia

Indeterminate GlobeNewswire

an hour ago

PyroGenesis Signs First Contract Toward New Titanium Powder Supply Agreement with U.S. Materials Distributor

Indeterminate GlobeNewswire